Go to content oder Go to navigation

PharMetrX15 - Our PhD program celebrates its 15th anniversary: in March 2008 PharMetrX was launched.

What we achieved: a steadily growing, internationally recognised, transdiciplinary program of enthustiastic PhD students with backgrounds as diverse as the disciplines of pharmacometrics. We are happy to qualify and have built a network of next generations of pharmacometricians in different areas – academia, industry, health authority, consultant company, hospital–; thus to foster research and training in our scientific discipline. Happy Birthday and many thanks for advancing PharMetrX together!



Graduate Research Training Program:
Pharmacometrics & Computational Disease Modelling

What is pharmacometrics?

How to find the right drug and the right dosing regimen for a patient? How to make use of the wealth of information available - about the drug, the patho-/physiology, in vitro, nonclinical and clinical data? Pharmacometrics is the integrative science using in silico models to understand the drug-patient-disease relationships and to optimise drug therapy for better outcomes. Eager to learn more?


Am I right here?

Are you about to finish or have you just finished your studies in pharmacy, pharmaceutical sciences, mathematics, bioinformatics, or some related field? Are you looking for a PhD in a fascinating research area at the intersection of clinical pharmacy and applied mathematics? Or are you a 1st year PhD student and looking for top-class training modules and a network of peers? Then you are right here!


What does PharMetrX offer?

We offer two programs: the PharMetrX Research+ Program and the PharMetrX Training+ Program. The first comprises an excellent research environment in the vibrant Berlin/Potsdam area, fascinating research projects in a highly relevant field, truly transdisciplinary supervision, and a competitive fellowship. Both programs offer a tailored training curriculum plus a network of peers. Interested?


News & Events

A1 Guest talk by Dr. Wolfgang Mück (Bayer) on 21 March 2023 (online)

entitled 'Role of of pharmacokinetics and pharmacodynamics in drug development'. We are looking forward to the talk of the renowned expert in the field of our A1 topic!


PharMetrX Training Curriculum 2023 continues

with the second academic module (A2) "Introduction to physiologically-based pharmacokinetics" at University of Potsdam, 27 - 31 March 2023.


89th PharMetrX & Research Group Meeting Workshop - Hot topic in pharmacometrics: Reloaded6

11 April 2023; Guest speaker: Prof. Dr. Bernd Meibohm, College of Pharmacy, University of Tennessee Health Science Center (UTHSC)

About us

The »Graduate Research Training Program PharMetrX: Pharmacometrics & Computational Disease Modelling« is a joint initiative in Germany between Freie Universität Berlin and the Universität Potsdam, bridging Pharmacy and Mathematics, and supported by a consortium of the research-driven pharmaceutical companies. PharMetrX is chaired by Charlotte Kloft, Professor of Clinical Pharmacy & Biochemistry, and Wilhelm Huisinga, Professor of Mathematical modelling and Systems biology.



Students join PharMetrX either as part of the PharMetrX Research+ Program or the PharMetrX Training+ Program. Every year between July and Mid September, we call for applications to join PharMetrX the following March.



PhD students of the PharMetrX Research+ Program contribute with their projects to the PharMetrX research platform; they are part of the joint PharMetrX research group bridging both universities and disciplines; co-/supervised by the two program chairs, have a mentor from industry and are financed by a competitive research fellowship.


Training & Network

The PharMetrX Training Curriculum and Network constitute two key components of the PharMetrX program. These are part of both, the PharMetrX Research+ Program as well as the PharMetrX Training+ Program.



Interested in applying to the PharMetrX Research+ Program or the PharMetrX Training+ Program? Here, you will find all the necessary information to proceed.